Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baqsimi vs IM Glucagon for Hypoglycemia in Japanese Patients
NCT03421379Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2018
- Primary completion
- Aug 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of glucagon in hypoglycemia, sponsored by Eli Lilly and Company. Started Feb 2018; status: completed.
02
Drugs
glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT03421379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03421379.